GHRP-2 10 mg/ml 10 ml |

About GHRP-2 | HilmaBiocare

GHRP-2 (Growth Hormone–Releasing Peptide-2) — Hilma Biocare

GHRP-2 is a synthetic growth hormone secretagogue from the Growth Hormone–Releasing Peptide (GHRP) class. It is a short peptide (hexapeptide) that stimulates growth hormone release primarily via the ghrelin (GHS-R) receptor pathway. In clinical and research contexts, compounds in this class are studied for endocrine effects, but their regulatory status and approved medical use vary by country.

General Overview

Class: Growth hormone secretagogue (GHRP) / peptide hormone modulator
Structure: Synthetic hexapeptide (GHRP-2)
Context of use: Research/medical context depends on jurisdiction; endocrine modulation under professional oversight where applicable

Potentially Observed Effects
(based on pharmacological mechanism and non-clinical reports)

Increased pulsatile growth hormone secretion in responsive individuals
Secondary changes in IGF-1 depending on dose, duration, and individual response
Appetite stimulation reported with ghrelin-pathway agonists
Potential influence on recovery-related processes via GH/IGF-1 signaling (individual variation)

Safety Information

GHRP-2 may be associated with endocrine and metabolic side effects. Reported risks include fluid retention, changes in glucose regulation, increased appetite, and alterations in cortisol and prolactin levels in susceptible individuals. As with other hormone-modulating agents, individual responses vary, and inappropriate use may disrupt normal endocrine balance.

Disclaimer: This text is provided for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always comply with the laws of your country and consult qualified medical professionals.